Creative Medical Technology Holdings (CELZ.OTC) announced proof of concept studies to demonstrate the efficacy and use-value of their ImmCelz immunotherapy product for the treatment of rheumatoid arthritis today. Rheumatoid…
Latest News
Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
Why Prospera Energy (PEI.V) might be a transformational investment opportunity in Canadian oil & gas
Sparc AI (SPAI.C) completes development of drone advanced target acquisition system
Plurilock (PLUR.V) lands $19 million deal, largest in their history
Rex Resources (OWN.V) continues gearing up with BC gold property